Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma
▪ Background: Outcomes for patients with diffuse large B-cell lymphoma (DLBCL) remain heterogeneous. Several clinical and molecular risk factors have been described, both at time of diagnosis (i.e., International Prognostic Index and cell of origin) and during therapy (i.e., interim PET scans). Howe...
Saved in:
Published in | Blood Vol. 130; no. Suppl_1; p. 826 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
08.12.2017
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!